Emerging therapies in HCM: The potential role of cardiac myosin inhibitors

Name: Emerging therapies in HCM: The potential role of cardiac myosin inhibitors
Uploaded: 2022-05-04T02:00:00+00:00
Duration: 21 min 3 s
Description: Ahmad Masri and prof. Deepak Bhatt explore the newer cardiac myosin inhibitors that go beyond traditional medical management for the treatment of hypertrop

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

SCOUT-HCM: Mavacamten in Adolescents With Symptomatic Obstructive Hypertrophic Cardiomyopathy
SCOUT-HCM: Mavacamten in Adolescents With Symptomatic Obstructive Hypertrophic Cardiomyopathy
ACC 2026 Clinical Insights: Advancing Cardiovascular Care
SCOUT-HCM: Mavacamten in Adolescents With Symptomatic Obstructive Hypertrophic Cardiomyopathy
Joseph Rossano, MD
- Joseph Rossano, MD
Precision Medicine in Obstructive HCM Care: The Promise of Cardiac Myosin Inhibitors
Precision Medicine in Obstructive HCM Care: The Promise of Cardiac Myosin Inhibitors
Hypertrophic Cardiomyopathy
Precision Medicine in Obstructive HCM Care: The Promise of Cardiac Myosin Inhibitors
Ahmad Masri, MD, MS
- Ahmad Masri, MD, MS
Aficamten improves peak oxygen uptake in obstructive HCM
Aficamten improves peak oxygen uptake in obstructive HCM
Hypertrophic Cardiomyopathy
Aficamten improves peak oxygen uptake in obstructive HCM
Caroline Coats, MD
- Caroline Coats, MD
Targeting cardiac energetics with cardiac mitotrope in nonobstructive HCM
Targeting cardiac energetics with cardiac mitotrope in nonobstructive HCM
ACC.24
Targeting cardiac energetics with cardiac mitotrope in nonobstructive HCM
Martin Maron, MD
- Martin Maron, MD

Emerging therapies in HCM: The potential role of cardiac myosin inhibitors

Recommended

Title